Anti-GAD1 (GAD67) monoclonal antibody MB62253
Specifications
| 50ul/100ul |
Background:
This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantigen and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Deficiency in this enzyme has been shown to lead to pyridoxine dependency with seizures. Alternative splicing of this gene results in two products, the predominant 67-kD form and a less-frequent 25-kD form.
Specificity:
glutamate decarboxylase 1
Alternative names:
CPSQ1; GAD; SCP
Species reactivity:
Human, Mouse, Rat
Host:
Mouse
Ig type:
PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
Immunogen:
Full-length protein expressed in 293T cell transfected with human GAD1 expression vector
Purification & Purity:
Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
Molecular weight:
66.9 kDa(Predicted)
Applications:
IHC, IP, WB
Usage:
WB: 1:200 - 1:1000, IHC: 1:50, IP: 4ug/mL
Storage:
PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
Precautions:
For research use only, not for use in diagnostic procedure.
More info:
Email: info@sobekbio.com
Orders:
Email: orders@sobekbio.com
